Mangrove Therapeutics Inc. — Form D

Mangrove Therapeutics Inc. of SACRAMENTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-07-31. The offering totals $5.0M, of which $2.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-07-31
• Form: D
• Accession: 0002111089-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $5.0M
• Amount sold: $2.5M
• Remaining: $2.5M
• Minimum investment: $25K
• Investors: 9
• Revenue range: No Revenues
• SEC file number: 021-592823

Issuer

• Name: Mangrove Therapeutics Inc.
• CIK: 0002111089
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 2108 N ST STE C, SACRAMENTO, CA, 95816
• Phone: (650) 485-3618

Officers, directors & promoters (3)

More

• CIK 2111089 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search